Cargando…

Oral Alitretinoin for the Treatment of Recalcitrant Pityriasis Rubra Pilaris

Treatment of pityriasis rubra pilaris is still challenging. We here present a 74-year-old woman who had not experienced stable remission of her skin symptoms during prior treatments including topical and systemic corticosteroids, phototherapy, orally administered acitretin, cyclosporine, methotrexat...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmitt, Laurenz, Inhoff, Oliver, Dippel, Edgar
Formato: Texto
Lenguaje:English
Publicado: S. Karger AG 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3094680/
https://www.ncbi.nlm.nih.gov/pubmed/21577368
http://dx.doi.org/10.1159/000327704
_version_ 1782203592826945536
author Schmitt, Laurenz
Inhoff, Oliver
Dippel, Edgar
author_facet Schmitt, Laurenz
Inhoff, Oliver
Dippel, Edgar
author_sort Schmitt, Laurenz
collection PubMed
description Treatment of pityriasis rubra pilaris is still challenging. We here present a 74-year-old woman who had not experienced stable remission of her skin symptoms during prior treatments including topical and systemic corticosteroids, phototherapy, orally administered acitretin, cyclosporine, methotrexate and adalimumab. A therapy with oral alitretinoin was started and tolerated very well. After a few weeks, skin condition improved significantly and itching and scaling disappeared. The present case shows that alitretinoin might be an alternative in the treatment of recalcitrant pityriasis rubra pilaris type I. Further studies are needed to investigate the benefit of this encouraging result.
format Text
id pubmed-3094680
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-30946802011-05-16 Oral Alitretinoin for the Treatment of Recalcitrant Pityriasis Rubra Pilaris Schmitt, Laurenz Inhoff, Oliver Dippel, Edgar Case Rep Dermatol Published: April 2011 Treatment of pityriasis rubra pilaris is still challenging. We here present a 74-year-old woman who had not experienced stable remission of her skin symptoms during prior treatments including topical and systemic corticosteroids, phototherapy, orally administered acitretin, cyclosporine, methotrexate and adalimumab. A therapy with oral alitretinoin was started and tolerated very well. After a few weeks, skin condition improved significantly and itching and scaling disappeared. The present case shows that alitretinoin might be an alternative in the treatment of recalcitrant pityriasis rubra pilaris type I. Further studies are needed to investigate the benefit of this encouraging result. S. Karger AG 2011-04-18 /pmc/articles/PMC3094680/ /pubmed/21577368 http://dx.doi.org/10.1159/000327704 Text en Copyright © 2011 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-No-Derivative-Works License (http://creativecommons.org/licenses/by-nc-nd/3.0/). Users may download, print and share this work on the Internet for noncommercial purposes only, provided the original work is properly cited, and a link to the original work on http://www.karger.com and the terms of this license are included in any shared versions.
spellingShingle Published: April 2011
Schmitt, Laurenz
Inhoff, Oliver
Dippel, Edgar
Oral Alitretinoin for the Treatment of Recalcitrant Pityriasis Rubra Pilaris
title Oral Alitretinoin for the Treatment of Recalcitrant Pityriasis Rubra Pilaris
title_full Oral Alitretinoin for the Treatment of Recalcitrant Pityriasis Rubra Pilaris
title_fullStr Oral Alitretinoin for the Treatment of Recalcitrant Pityriasis Rubra Pilaris
title_full_unstemmed Oral Alitretinoin for the Treatment of Recalcitrant Pityriasis Rubra Pilaris
title_short Oral Alitretinoin for the Treatment of Recalcitrant Pityriasis Rubra Pilaris
title_sort oral alitretinoin for the treatment of recalcitrant pityriasis rubra pilaris
topic Published: April 2011
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3094680/
https://www.ncbi.nlm.nih.gov/pubmed/21577368
http://dx.doi.org/10.1159/000327704
work_keys_str_mv AT schmittlaurenz oralalitretinoinforthetreatmentofrecalcitrantpityriasisrubrapilaris
AT inhoffoliver oralalitretinoinforthetreatmentofrecalcitrantpityriasisrubrapilaris
AT dippeledgar oralalitretinoinforthetreatmentofrecalcitrantpityriasisrubrapilaris